These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CDK11 Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725 [TBL] [Abstract][Full Text] [Related]
3. Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation. Duan Z; Zhang J; Choy E; Harmon D; Liu X; Nielsen P; Mankin H; Gray NS; Hornicek FJ Clin Cancer Res; 2012 Sep; 18(17):4580-8. PubMed ID: 22791884 [TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth. Zhou Y; Han C; Li D; Yu Z; Li F; Li F; An Q; Bai H; Zhang X; Duan Z; Kan Q Sci Rep; 2015 May; 5():10433. PubMed ID: 25990212 [TBL] [Abstract][Full Text] [Related]
5. Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system. Feng Y; Sassi S; Shen JK; Yang X; Gao Y; Osaka E; Zhang J; Yang S; Yang C; Mankin HJ; Hornicek FJ; Duan Z J Orthop Res; 2015 Feb; 33(2):199-207. PubMed ID: 25348612 [TBL] [Abstract][Full Text] [Related]
6. Critical role of CDK11(p58) in human breast cancer growth and angiogenesis. Chi Y; Huang S; Peng H; Liu M; Zhao J; Shao Z; Wu J BMC Cancer; 2015 Oct; 15():701. PubMed ID: 26470709 [TBL] [Abstract][Full Text] [Related]
7. Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development. Li T; Inoue A; Lahti JM; Kidd VJ Mol Cell Biol; 2004 Apr; 24(8):3188-97. PubMed ID: 15060143 [TBL] [Abstract][Full Text] [Related]
8. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells. San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101 [TBL] [Abstract][Full Text] [Related]
9. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin. Mendoza-Villanueva D; Zeef L; Shore P Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690 [TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase 11(p110) activity in the absence of CK2. Sachs NA; Vaillancourt RR Biochim Biophys Acta; 2003 Dec; 1624(1-3):98-108. PubMed ID: 14642819 [TBL] [Abstract][Full Text] [Related]
11. The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer. Zhou Y; Shen JK; Hornicek FJ; Kan Q; Duan Z Oncotarget; 2016 Jun; 7(26):40846-40859. PubMed ID: 27049727 [TBL] [Abstract][Full Text] [Related]
12. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection. Loyer P; Trembley JH; Grenet JA; Busson A; Corlu A; Zhao W; Kocak M; Kidd VJ; Lahti JM J Biol Chem; 2008 Mar; 283(12):7721-32. PubMed ID: 18216018 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11. Liao Y; Sassi S; Halvorsen S; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z Sci Rep; 2017 Mar; 7():43941. PubMed ID: 28262798 [TBL] [Abstract][Full Text] [Related]
14. The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. Feng Y; Qi W; Martinez J; Nelson MA Biochem Biophys Res Commun; 2005 Jun; 331(4):1503-9. PubMed ID: 15883043 [TBL] [Abstract][Full Text] [Related]
15. Correction to: Transcriptional activation of CBFβ by CDK11 Feng Y; Liao Y; Zhang J; Shen J; Shao Z; Hornicek F; Duan Z Cell Commun Signal; 2019 Oct; 17(1):138. PubMed ID: 31665012 [TBL] [Abstract][Full Text] [Related]
16. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma. Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810 [TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326 [TBL] [Abstract][Full Text] [Related]
19. CDK11(p58) is required for the maintenance of sister chromatid cohesion. Hu D; Valentine M; Kidd VJ; Lahti JM J Cell Sci; 2007 Jul; 120(Pt 14):2424-34. PubMed ID: 17606997 [TBL] [Abstract][Full Text] [Related]
20. Casein kinase 2 interacts with cyclin-dependent kinase 11 (CDK11) in vivo and phosphorylates both the RNA polymerase II carboxyl-terminal domain and CDK11 in vitro. Trembley JH; Hu D; Slaughter CA; Lahti JM; Kidd VJ J Biol Chem; 2003 Jan; 278(4):2265-70. PubMed ID: 12429741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]